probably accelerated the fatal course in one of them. ' The same cause might explain the outcome in other cases of fatal side effects of valproate.' The families ofsuch children need to be investigated because (a) a common cause offatal valproate toxicity might be found, (b) a procedure to detect people at risk might be advised-for example, measuring plasma ammonia concentrations for initial monitoring oftreatment-and (c) confidence about using the drug for children and adults without a metabolic abnormality might be restored. 
Apheresis in the management of loiasis with high microfilariaemia and renal disease
Membranous glomerulopaihy is sometimes associated with loiasis," a common disease in western and central Africa. We describe a case in which renal symptoms improved after treatment ofloiasis with apheresis followed by diethylcarbamazine.
Case report
A 28 year old man, who had been born in Cameroon but had lived in France from 1976, presented with recurring episodes of itching. Loiasis was diagnosed with microfilariaemia of 35 x 106/1. The eosinophil count was 1 6x 109/1. Stools and urine were negative for parasites; results of serological tests were negative for syphilis, hepatitis B surface antigen, and schistosomas and positive for filarias and malaria. Serum creatinine concentration was 122 pmol/l (1-4 mg/100 ml). Urine before treatment with'diethylcatbamazine; The standard procedure for collection of platelets was followed by centrifuigation at 4800 rpm. About 3-2 litres of blood were processed in seven cycles during each session of apheresis. Three sessions were performed on consecutive days at-midda, when the microfilariaemia was highest.-The table shows effect of the three sessions on the number of microfilarias in the blood. About 2 8x 108microfilarias were extracted during the three sessions. This procedure was well tolerated with the platelet count falling from 383 to 140x 109 platelets/I. He was then treated with diethylcarbamazine, starting with low doses (5 mg/day) that were progressively increased; prednisolone (0 5 mg/kg/day) was added for the first few days. Transient moderate itching occurred. After 15 days of treatment (diethylcarbamazine 400 mg/day) no microfilarias were detectable. After nine months (diethylcarbamazine 100 mg/day) microfilarias remained undetectable, the haematuria had cleared,'and proteinuria ranged between 0-4 and 1 0 g/24h. Serum creatinine concentration was 114 1imol/l (1-3 mg/100 ml).
Comment
In loiasis with high microfilarinaemia diethylcarbamazine may be responsible for serious side effects such'as encephalitise due to the lysis of microfilarias, and the risks oftreatment can be more important than the risks associated with the disease. Loiasis with visceral complications such as renal or cardiac conditions, however, should be treated. In our patient the loiasis was treated because it was considered to be the cause of the membranous glomerulopathy and we hoped to relieve the renal symptoms. Glomerulopathy associated with loiasis is believed to be immunologically mediated'-3; massive lysis of microfilarias at the start of treatment with diethylcarbamazin'e induces an antigen overload that could worsen renal symptoms, and so the microfilarinaemia should be reduced before specific chemotherapy. In 1983 Muylle et al first reported the success of apheresis in reducing microfilariaemia in two cases,5 showing that microfilarias are concentrated in the buffy coat by discontinuous flow centrifugation and can be extracted with a blood cell separator. To our knowledge this technique has never been used in patients with loiasis and renal disease. In this case, with a follow up of nine months, we observed an improvement in urinary sediment -and stabilisation of renal function. Further observations are warranted to confirm the benefit of specific treatment for renal symptoms in the management of such patients. Renal artery occlusion in patients with renovascular hypertension treated with captopril
In patients with renal artery stenosis reversible renal failure of the kidney on the affected side-may occur during treatment with captopril. We describe three patients with atherosclerotic renal artery stenosis who developed occlusion of the affected renal artery during treatment with captopril while awaiting percutaneous transluminal angioplasty. This was preceded by long term treatment with captopril (13-21 weeks), which is said to guide prediction of curability. slmol/l (1-01 mg/100 ml), creatinine clearance 100 mI/min) (ta'ble) . Treatment 
